dallas tx 7/22/2010 11:15:36 PM
News / Business

Top Penny Stock Gainers Today include DSTI, VCGH, CYTR

Subscribe to our FREE penny stock email alert service by visiting http://www.pennytrader.com/sign-up/

Active Penny Stocks in the News

 

PennyTrader.com presents a range of the hottest penny stocks on the OTC and OTCBB market today. In addition to daily hot stock alerts, PennyTrader.com‘s new penny stock alert service is fast becoming the premier stock alert list to be on.

 

Subscribe to our FREE penny stock email alert service by visiting http://www.pennytrader.com/sign-up/

 

DayStar Technologies, Inc. (Nasdaq: DSTI) reached up 59.99% in morning trading to $2.24 with 1M shares traded. DayStar Technologies, Inc. (Nasdaq:DSTI - News), a developer of solar photovoltaic products based on CIGS thin-film deposition technology announced today it is pursuing a strategy for offshore manufacturing of its CIGS solar modules.

For detailed quote and full article http://www.pennytrader.com/quotes/DSTI.php

 

VCG Holding Corp. (Nasdaq: VCGH) was up 15.15% in morning trading to $1.90 with 150K shares traded. VCG Holding Corp. (Nasdaq:VCGH - News), a growing and leading consolidator and operator of adult nightclubs, announced today that it received a non-binding proposal (the "Proposal") from Family Dog, LLC ("Purchaser"), an entity affiliated with the Company's Chairman and Chief Executive Officer, Troy Lowrie, and Lowrie Management, LLLP ("Lowrie Management") to acquire all of the outstanding common stock of the Company (other than the shares held by Purchaser, its affiliates and certain other investors) for $2.10 per share in cash (the "Acquisition").

For detailed quote and full article http://www.pennytrader.com/quotes/VCGH.php

 

CytRx Corporation (NASDAQ: CYTR) was up 13.33% in morning trading to $.85 with 1M shares traded. CytRx Corporation (NASDAQ: CYTR - News), a biopharmaceutical company specializing in oncology, today announced that a 44-year-old female patient with advanced acute promyelocytic leukemia (APL) achieved molecular complete remission with no evidence of disease in the blood cells and/or bone marrow following treatment with CytRx’s oncology drug candidate tamibarotene.

For detailed quote and full article http://www.pennytrader.com/quotes/CYTR.php

 

Subscribe to our FREE penny stock email alert service by visiting http://www.pennytrader.com/sign-up/

 

About PennyTrader.com

 

PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks
in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.

 

Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report

For complete disclosure information go to http://www.pennytrader.com/disclosure/

 

PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to http://www.pennytrader.com/disclaimer/